reports

NowVertical Group Reports Second Quarter 2025 Financial Results

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (“NOW” or the “Company”), a leader in AI-driven…

10 months ago

AI adoption is strong among entry-level workers across sectors and economies – and it’s making work life easier and more enjoyable, reports Generation

Analysis finds that 65% of entry-level employees are using AI, and most are self-taught power users.Most users are experiencing clear…

10 months ago

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2025 16:35 ET  | Source: Vor Biopharma CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:…

10 months ago

Foresight Reports Second Quarter 2025 andFirst Half 2025 Financial Results

NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the…

10 months ago

CNRC Reports Q2 2025 Financials Period Ending June 30, 2025; Provides Shareholder Update on Portfolio Companies

CHARLESTON, W.Va., Aug. 15, 2025 /PRNewswire/ -- Surya Oil & Gas Corp. (OTCID: CNRC), ( "SOGC" or the "Company" ) formerly…

10 months ago

Plus Therapeutics Reports Stockholders Equityin Excess of $2.5 million in Compliance with Nasdaq Equity Requirements

August 15, 2025 07:30 ET  | Source: Plus Therapeutics Inc. HOUSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) --  Plus Therapeutics, Inc.…

10 months ago

IndoStar Capital Finance reports PAT 535 crore, AUM 7,783 crore, Disbursement 858 crore

MUMBAI, India, Aug. 14, 2025 /PRNewswire/ -- IndoStar, a middle-layered non-banking finance company (NBFC) registered with the Reserve Bank of India, announced its…

10 months ago

Nexteer Reports Strong First-Half 2025 Results

Driven by Growth with China OEMs, Technology Leadership & Strategic Expansion   AUBURN HILLS, Mich., Aug. 13, 2025 /PRNewswire/ --…

10 months ago

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…

10 months ago

Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home…

10 months ago